Vijaya Diagnostic Centre Ltd.

As of June 30, 2026, Vijaya Diagnostic Centre Ltd. carries a market capitalization of 139.12B, placing it among publicly traded companies globally. Its enterprise value stands at 139.12B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Vijaya Diagnostic Centre Ltd.'s next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Vijaya Diagnostic Centre Ltd. has 102.90M shares outstanding.

As of June 30, 2026, Vijaya Diagnostic Centre Ltd. trades at a trailing price-to-earnings ratio of 76.03.

As of June 30, 2026, Vijaya Diagnostic Centre Ltd. trades at an EV/EBITDA multiple of 39.34 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 16.49 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 53.72 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 139.12B versus a market cap of 139.12B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 3.57M in revenue per employee across its workforce of 2,362.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Vijaya Diagnostic Centre Ltd. recorded 628.47M in income tax expense. That works out to an effective tax rate of 25.58, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.46B, leaving 1.83B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Vijaya Diagnostic Centre Ltd.'s stock has gained approximately 40.89% over the past 52 weeks. The 50-day moving average sits at 1,469.97, while the 200-day moving average is 1,222.43.

Over the twelve months ended June 30, 2026, Vijaya Diagnostic Centre Ltd. generated 8.44B in revenue and converted that into 1.83B in net income, yielding earnings per share of 17.74. EBITDA reached 3.54B, while operating income came in at 2.59B.

Over the twelve months ended June 30, 2026, Vijaya Diagnostic Centre Ltd. posted a gross margin of 88.63, reflecting its pricing power and cost economics. The operating margin of 30.70 and net profit margin of 21.67 provide insight into operational efficiency.